 |
 |

APOE Genotype, Family History of Dementia, and Alzheimer Disease Risk
A 6-Year Follow-up Study
Wenyong Huang, MD;
Chengxuan Qiu, MD, PhD;
Eva von Strauss, PhD;
Bengt Winblad, MD, PhD;
Laura Fratiglioni, MD, PhD
Arch Neurol. 2004;61:1930-1934.
Background Both family aggregation and apolipoprotein E (APOE) 4 allele are well-known risk factors for dementia, but the relation between these two factors remains unclear.
Objective To explore whether the risk of dementia and Alzheimer disease (AD) due to a positive family history is explained by APOE genotypes.
Design Community-based cohort study.
Setting The Kungsholmen district of Stockholm, Sweden.
Participants A total of 907 nondemented people 75 years or older, followed up for 6 years to detect incident dementia and AD cases according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition.
Main Outcome Measures Risk of dementia and AD by Cox proportional hazards models after controlling for several potential confounders.
Results Subjects who had at least 2 siblings with dementia were at an increased risk of AD. Individuals with both APOE 4 allele and at least 2 affected first-degree relatives had a higher risk of dementia and AD compared with those without these 2 factors. Similar results were obtained for history of dementia separately in parents or siblings. Among the 4 allele carriers, subjects with 2 or more first-degree demented relatives had increased risk of dementia and AD, whereas no increased risk was detected among non 4 carriers.
Conclusions Family history of dementia was associated with an increased risk of dementia and AD in this very old population, but only among APOE 4 carriers. This suggests the existence of other genetic or environmental risk factors that may be active in the presence of the APOE 4 allele.
Authors Affiliations: Aging Research Center, Division of Geriatric Epidemiology and Medicine, Department of Neurotec, Karolinska Institutet and Stockholm Gerontology Research Center, Stockholm, Sweden.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
ApoE Genotype and Family History in Patients With Dementia and Cognitively Intact Spousal Controls
Zintl et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2009;24:349-352.
ABSTRACT
Familial aggregation of parkinsonism in progressive supranuclear palsy
Kaat et al.
Neurology 2009;73:98-105.
ABSTRACT
| FULL TEXT
Influence of Cognitive Status, Age, and APOE-4 Genetic Risk on Brain FDDNP Positron-Emission Tomography Imaging in Persons Without Dementia
Small et al.
Arch Gen Psychiatry 2009;66:81-87.
ABSTRACT
| FULL TEXT
Dementia of the Alzheimer Type
Jalbert et al.
Epidemiol Rev 2008;30:15-34.
ABSTRACT
| FULL TEXT
The Role of Apolipoprotein E in Cognitive Decline and Delirium after Bypass Heart Operations
Tagarakis et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:223-228.
ABSTRACT
Apolipoprotein E {varepsilon}4 and Age at Onset of Sporadic and Familial Alzheimer Disease in Caribbean Hispanics
Olarte et al.
Arch Neurol 2006;63:1586-1590.
ABSTRACT
| FULL TEXT
Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR Study
Cortes et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:131-136.
ABSTRACT
Children of Alzheimer Patients: An Overview
Jarvik and Blazer
J Geriatr Psychiatry Neurol 2005;18:181-186.
Absence of 12/15 Lipoxygenase Reduces Brain Oxidative Stress in Apolipoprotein E-Deficient Mice
Chinnici et al.
Am. J. Pathol. 2005;167:1371-1377.
ABSTRACT
| FULL TEXT
|